Pharmaceutical Executive
Providers and patients fish for that delicate balance between access and abandonment.
Alison King
Advertisement
Articles by Alison King
Advertisement
Latest Updated Articles
Who Pays for Specialty Medicines?November 1st 2012
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
2
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
3
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
4
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
5